We are live on ! Find out more
MOBI icon

Mobia Medical

11.85 USD
-0.01
0.08%
At close Updated Nov 20, 4:00 PM EST
1 day
-0.08%
5 days
-8.49%
1 month
31.08%
3 months
8.22%
6 months
-7.06%
Year to date
0.85%
1 year
0.85%
5 years
0.85%
10 years
0.85%
 

About: Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 0%
Neutral 100%
Negative 0%
Neutral
GlobeNewsWire
4 days ago
Mobia Medical to Participate in the Piper Sandler 38th Annual Healthcare Conference
AUSTIN, Texas, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced that members of management will present and host one-on-one investor meetings at the upcoming Piper Sandler 38th Annual Healthcare Conference in New York. The presentation will take place on Tuesday, December 1, 2026, at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.
Mobia Medical to Participate in the Piper Sandler 38th Annual Healthcare Conference
Neutral
Seeking Alpha
15 days ago
Mobia Medical, Inc. (MOBI) Q3 2026 Earnings Call Transcript
Mobia Medical, Inc. ( MOBI ) Q3 2026 Earnings Call November 5, 2026 4:30 PM EST Company Participants Richard Foust - CEO, President & Director Nelson Curnes - Chief Financial Officer Conference Call Participants Louisa Smith - Gilmartin Group LLC Travis Steed - BofA Securities, Research Division Robert Marcus - JPMorgan Chase & Co, Research Division Jacqueline Raimo - BTIG, LLC, Research Division Andrew Curtis - Wolfe Research, LLC Presentation Operator Good afternoon, and welcome to the Mobia Medical Third Quarter 2026 Earnings Conference Call. [Operator Instructions] Please note that today's call is being recorded.
Mobia Medical, Inc. (MOBI) Q3 2026 Earnings Call Transcript
Neutral
MarketBeat
16 days ago
What Mobia Medical (MOBI) Said on Its Q3 Earnings Call
Mobia Medical NASDAQ: MOBI raised its full-year revenue forecast after third-quarter sales rose 73%, driven by broader adoption of its Vivistim therapy at new and existing programs.
What Mobia Medical (MOBI) Said on Its Q3 Earnings Call
Neutral
GlobeNewsWire
16 days ago
Mobia Medical Reports Third Quarter 2026 Financial Results
Delivers revenue growth of 73% in the third quarter and raises full year 2026 revenue guidance AUSTIN, Texas, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today reported financial results for the quarter ended September 30, 2026. Third Quarter 2026 and Recent Highlights Reported revenue of $15.6 million, representing 73% growth over the prior year period Achieved gross margin of 83.2% Increased average active territories in the quarter to 40, compared to 22.5 in the prior year period Announced inclusion of paired VNS in the updated 2026 AHA Guideline for stroke recovery Increased full year 2026 revenue guidance to be in the range of $57.0 million to $57.5 million compared to prior range of $54.0 million to $56.0 million “This quarter, we delivered our strongest results yet.
Mobia Medical Reports Third Quarter 2026 Financial Results
Neutral
GlobeNewsWire
18 days ago
Mobia Medical to Participate in the 8th Annual Wolfe Research Healthcare Conference
AUSTIN, Texas, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced that members of management will participate in a fireside chat and host one-on-one investor meetings at the upcoming 8th Annual Wolfe Research Healthcare Conference in New York. The fireside chat will take place on Tuesday, November 10, 2026, at 12:20 p.m.
Mobia Medical to Participate in the 8th Annual Wolfe Research Healthcare Conference
Neutral
GlobeNewsWire
1 month ago
Mobia Medical to Report Third Quarter 2026 Financial Results on November 5, 2026
AUSTIN, Texas, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced that the Company will report third quarter 2026 financial results on Thursday, November 5, 2026. Mobia Medical's management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.
Mobia Medical to Report Third Quarter 2026 Financial Results on November 5, 2026
Neutral
GlobeNewsWire
2 months ago
Mobia Medical Announces Addition of Paired VNS to Updated AHA Stroke Guidelines
AUSTIN, Texas, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced that implantable paired Vagus Nerve Stimulation (VNS) has been recognized in the 2026 Guideline for Adult Stroke Rehabilitation and Recovery: A Guideline From the American Heart Association (AHA) and American Stroke Association (ASA), published August 27, 2026 in Stroke as a treatment option to improve upper-limb function and impairment for chronic stroke survivors.
Mobia Medical Announces Addition of Paired VNS to Updated AHA Stroke Guidelines
Neutral
Seeking Alpha
3 months ago
Mobia Medical, Inc. (MOBI) Q2 2026 Earnings Call Transcript
Mobia Medical, Inc. (MOBI) Q2 2026 Earnings Call Transcript
Mobia Medical, Inc. (MOBI) Q2 2026 Earnings Call Transcript
Neutral
MarketBeat
3 months ago
Mobia Medical Q2 Earnings Call Highlights
Mobia Medical NASDAQ: MOBI reported second-quarter revenue of $13.5 million, up 102% from $6.7 million a year earlier, as adoption of its Vivistim paired vagus nerve stimulation therapy expanded across new and existing stroke-care programs.
Mobia Medical Q2 Earnings Call Highlights
Neutral
GlobeNewsWire
3 months ago
Mobia Medical Reports Second Quarter 2026 Financial Results
AUSTIN, Texas, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today reported financial results for the quarter ended June 30, 2026. Second Quarter 2026 and Recent Highlights Reported revenue of $13.5 million, representing 102% growth over the prior year period Achieved gross margin of 83.2% Announced publication of two-year VNS-REHAB follow up data in Neurology®, demonstrating durable and clinically meaningful improvement in upper-limb motor function, activities of daily living, and quality of life Completed initial public offering, raising approximately $134.0 million in net proceeds Appointed Myriam Curet, M.D.
Mobia Medical Reports Second Quarter 2026 Financial Results
Price charts implemented using Lightweight Charts™